Direct contract research and specialized ODM development programs designed for international pharmaceutical groups and clinical-grade nutraceutical manufacturers.
Validated HPLC, GC, and chromatographic fingerprinting to secure batch-to-batch chemical repeatability and international monograph compliance.
Explore Specifications
High-throughput isolation and bio-guided fractionation to pinpoint target alkaloids, polyphenols, and saponins with commercial efficiency.
Explore Specifications
Rigorous cell-line screening, metabolic pathway assays, and receptor-binding evaluations to establish mechanism-of-action before clinical phases.
Explore Specifications
Spatial-temporal metabolic profiling across diverse harvesting seasons, altitudes, and plant tissues to optimize raw ingredient procurement.
Explore Specifications
Full toxicological dossiers including acute LD50, sub-chronic toxicity, and specialized disease animal models to support global regulatory filings.
Explore Specifications
GCP-compliant human trials for functional claim substantiation, pharmacokinetic bioavailability charting, and New Drug Application (NDA) submissions.
Explore Specifications
Proprietary multi-stage extraction and column separation workflows designed to produce active pharmaceutical ingredients (APIs) at commercial scale.
Explore Specifications
Developing orthogonal testing protocols to eliminate adulteration, measure degradation pathways, and meet pharmacopeial standards worldwide.
Explore SpecificationsOvercoming natural chemical heterogeneity through synchronized contract research, molecular fingerprinting, and standardized CDMO process engineering.
Unlike synthetic single-molecule synthesis, botanical matrices are fundamentally heterogeneous. Soil microbiome composition, seasonal rainfall variations, and thermal stress introduce significant shifts in active secondary metabolites. MedGence’s Exacting Standards deploy multi-dimensional chromatographic profiling (HPTLC, HPLC-DAD, and GC-MS) across all raw materials.
By determining the critical harvest window and geo-climatic origin across nearly 400 single-herb monographs, our ODM pipeline transforms unpredictable natural harvests into chemically defined, reproducible therapeutic raw materials.
Traditional Chinese Medicine (TCM) contains millennia of empirical safety and multi-target efficacy data. However, international regulatory adoption is hindered by the lack of clear mechanism elucidation and modern pharmacokinetics.
Having completed modern pharmaceutical research on 83 classic TCM formulas and registered 56 hospital preparations, we engineer exact extraction fractions that retain synergistic medicinal interactions while purifying out inert polysaccharides, heavy metal contaminants, and toxic alkaloids.
The traditional pharmaceutical development model is fragmented: academic labs execute basic screening, contract research organizations run animal trials, and third-party toll manufacturers attempt mass production. This fragmentation results in loss of know-how and formulation failures during pilot scale-up.
MedGence bridges this gap with an end-to-end infrastructure. Our technical leadership directly supervises our dedicated pilot plants and collaborative cGMP facilities, ensuring validated benchtop extraction parameters translate seamlessly into metric-ton commercial runs.
International commercial buyers now operate under heightened scrutiny from the FDA, EMA, TGA, and NMPA. Compare conventional toll contract extractors with MedGence’s integrated scientific CDMO model.
| Evaluation Parameter | Commodity Contract Extractors (OEM) | MedGence Exacting Standards ODM / CDMO | Strategic Industry Benefit |
|---|---|---|---|
| Raw Material Sourcing | Commodity spot-market sourcing; unmonitored seasonality; high batch variance. | Multi-region geo-climatic potency mapping; optimized chronobiological harvesting. | Maximum Yield & Potency |
| Analytical Verification | Basic TLC testing, UV-Vis spectrophotometry prone to matrix interference. | Orthogonal HPLC-DAD-MS, GC-MS/MS, HPTLC fingerprinting, heavy metal ICP-MS. | Audit-Proof Monograph |
| Efficacy Substantiation | Relies on third-party public literature; no proprietary bio-assays conducted. | In vitro receptor assays, target cell lines, and GLP-standard in vivo animal models. | Proprietary IP Protection |
| Clinical Translation | None; client bears complete burden and liability of clinical trial design. | Phase I–IV clinical study architecture, ethics board management, and trial reporting. | Turnkey Drug Registration |
| Scalability & Delivery | Fixed toll-processing lines with high minimum orders and limited dosage formats. | Flexible pilot-to-bulk suites: liquids, capsules, softgels, granules, volatile oils. | Rapid Time-to-Market |
From raw botanical harvest to commercial dosage formulation, every stage of our ODM process is subject to quantitative scientific controls.
Botanical potency is governed by abiotic variables. Our botanical scientists evaluate secondary metabolite concentrations across diverse regions, altitudinal zones, and plant parts (rhizomes, leaves, fruits, bark). We determine exact harvest windows to lock in peak bioactive densities.
We engineer precision analytical monographs utilizing High-Performance Liquid Chromatography (HPLC), High-Performance Thin-Layer Chromatography (HPTLC), Gas Chromatography (GC), and mass spectrometry to identify markers and ensure no chemical drift between manufacturing batches.
Lab extraction frequently collapses at pilot scale due to heat sensitivity or improper solvents. Our process engineers systematically optimize extraction temperature, fluid dynamics, membrane filtration, macroporous resin adsorption, and low-temperature spray drying.
Before commercial formulation, every natural compound or formulation candidate undergoes comprehensive safety dossiers: median lethal dose (LD50), acute toxicity, sub-chronic toxicity, Ames bacterial reverse mutation tests, and target cellular signaling evaluations.
For dietary supplements requiring structure-function claims or innovative natural drugs requiring NDA approval, we design and supervise human clinical trials. Leveraging relationships with top teaching hospitals, we conduct Phase I through Phase IV studies.
Bioactive integrity can be compromised during dosage manufacturing. Our formulation scientists solve bioavailability, dispersion, and palatability challenges, providing stable finished products across a wide spectrum of customer delivery formats.
Eliminating market entry barriers across North America, Europe, and Asia-Pacific through harmonized quality standard dossiers and ironclad intellectual property security.
Navigating the intersection between food supplements, natural health products, and pharmaceutical botanical drugs requires rigorous regulatory documentation. MedGence produces Common Technical Document (CTD) Module 3 (Quality/CMC) files designed for direct submission to:
Commercial competitive advantage depends on the inviolable security of proprietary formulas, unique extraction parameters, and screening results. Under our entrusted contract research and manufacturing model:
Real-world execution showing how our exact ODM capabilities translate across commercial sectors.
Context: A multinational pharmaceutical brand required a standardized botanical extract targeting endothelial health and metabolic syndrome.
Execution: We screened 14 harvesting regions, developed an orthogonal HPLC method for three key active flavonoids, isolated them using countercurrent chromatography, completed an in vivo rodent hypertension model, and transferred the process into 500kg commercial batch manufacturing.
Context: A premium skincare conglomerate sought a patented natural polyphenol complex with documented anti-inflammatory and cellular repair capabilities.
Execution: Conducted in vitro human keratinocyte (HaCaT) UV-induced oxidation models, established LD50 and patch-test dermal irritation records, engineered a subcritical solvent extraction yielding 98% purity, and formulated a clear, oxidation-resistant concentrated liquid active.
Context: A provincial TCM hospital needed to transition a historically proven clinical formula into an officially registered, industrialized hospital preparation.
Execution: Formulated comprehensive single-herb quality monographs, solved bitter taste and sedimentation in an oral liquid formulation, completed acute toxicity studies, and drafted the complete NMPA registration dossier, securing official hospital preparation approval.
Integrating computational cheminformatics, real-time Process Analytical Technology (PAT), and continuous automated flow extraction.
By 2026, MedGence is integrating machine-learning molecular docking models with our database of hundreds of thousands of research batches. This enables predictive identification of botanical compounds capable of binding complex disease targets prior to running wet-lab bioassays.
Transitioning conventional batch vessel extraction into enclosed, continuous micro-reactor and countercurrent extraction lines. Online near-infrared (NIR) and ultra-HPLC PAT sensors monitor active compound concentrations in real time, automatically adjusting solvent flow and temperature.
Developing hybrid manufacturing platforms combining wild-plant extraction with enzymatic biotransformation and precision yeast fermentation, securing rare botanical glycosides and saponins that occur in trace quantities in nature without over-harvesting wild resources.
Our rigorous analytical and contract manufacturing methodologies are validated by ongoing collaborations with national healthcare leaders and academic medical centers.
Tongrentang Group
CR Sanjiu
Sunflower Pharma
Livzon Pharma
Dihon Pharma
Golden Throat
Yangtzi River Pharma
Gofar Chuanshan
Humanwell Group
SCIMYTH Pharma
Hanfang Pharma
Luoxin Pharma
Zhongsheng Pharma
Brilliance & Abundance
Apeloa Pharma
Heng Chang Pharma
Baotou TCM
Kamp Medicine
Santo Pharma
Kangshou Pharma
Juwang Pharma
Tcmages Pharma
Ruihe Pharma
CR Jinchan
Kangmei Pharma
Tianjicaotang
Kingstone Unite
Shuguang Hospital
Hunan TCM Hospital
1st Hosp Hunan TCM
Second Xiangya CSU
2nd Hosp Hunan TCM
Zhuzhou OrthopedicsClear answers addressing technical scope, regulatory submissions, technology transfers, and intellectual property safety.
Select a specialized development module or engage our comprehensive end-to-end CDMO pipeline for rapid international deployment.
Complete chromatographic development, method validation parameters (ICH Q2), and transfer documentation for global regulatory filings.
Request Catalog & Specs
Isolating target botanical fractions, identifying lead molecular candidates, and designing cost-effective industrial extraction routes.
Request Catalog & Specs
Primary cell cultures and organoid models to prove active antioxidant, metabolic, and anti-inflammatory pathways with quantifiable data.
Request Catalog & Specs
Evaluating geospatial metabolite concentrations across varied regions to establish an unshakeable, high-potency raw ingredient supply chain.
Request Catalog & Specs
Full animal bio-distribution, dose-ranging, chronic toxicity, and pharmacodynamics reports required for regulatory clearance.
Request Catalog & Specs
Hospital-partnered clinical trial administration for functional supplement claim verification and drug dossier submissions.
Request Catalog & Specs
Pilot-to-commercial scale purification utilizing macroporous adsorption, countercurrent chromatography, and low-temperature drying.
Request Catalog & Specs
Comprehensive pharmacopeial alignment (USP, EP, CP) establishing chemical reference standards and precise degradation profiles.
Request Catalog & Specs